P&G (PG) Q1 2027 Earnings Call Transcript

P&G (PG) reported Q1 2027 earnings with organic sales growth across all 10 product categories and 6 regions. North America and Europe grew 3% and 4% respectively, while Greater China saw 8% growth. Core EPS was $2, down 1 point YoY. The company maintained guidance for fiscal 2027 and highlighted successful product launches like Pantene's Abundant and Strong, Pampers Amoira, and Fairy Dish.

Original reporting
Published Oct 22, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
P&G (PG) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PGNeutralMed
01

Why it matters

The earnings release offers fresh data on revenue growth and margin trends, informing short‑term price expectations.

02

Market read

Large‑cap consumer staple earnings with mixed signals on growth and profitability, relevant for sector positioning.

03

What to watch

Strong cash flow productivity and $3.9 bn share‑return program may offset short‑term margin concerns.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

P&G provided its Q1 2027 earnings call transcript, outlining organic sales growth, category performance, and financial metrics.

Company-level read

Ticker impact

$PGNeutralHigh confidence
Context

P&G disclosed Q1 2027 earnings with core EPS $2, margin compression and maintained fiscal guidance.

Expected impact

likely modest downside as investors digest lower margins despite revenue growth

Evidence & confidence

Revenue grew across categories and regions, but core gross margin fell 150 bps and operating margin fell 80 bps, offsetting the EPS beat.

Market effects

Consumer staples peers may see similar margin pressure as input costs rise.

North America and Greater China growth may boost regional consumer‑goods sentiment.

Large‑cap consumer staple earnings influence broader market direction.

Counterpoint

Despite margin compression, continued share gains and cash returns could support upside.

Key entities

  • Procter & Gamble

    Consumer‑goods conglomerate reporting Q1 2027 results.

Related articles

$PGMed

P&G Plans To Cut Up To 30% Product Supply Jobs By 2030; Confirms FY27 Outlook

Procter & Gamble (P&G) plans to cut 20-30% of product supply jobs by 2030, aiming for $10B in productivity savings. The company maintained its FY27 outlook, projecting 2-4% net sales growth and 1-3% organic sales growth. P&G also expects $1.8B in annual productivity savings and $30B in growth opportunities. Shares gained 0.30% to $168.35 in overnight trading.

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November